$ACXP

Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Acurx Pharmaceuticals (NASDAQ:ACXP), AlphaTON Capital (NASDAQ:ATON)

Shares of Confluent Inc ( NASDAQ:CFLT ) rose sharply in pre-market trading. Confluent is exploring a sale after attracting acquisition interest from tech firms and private equity investors, according to Reuters. Confluent shares jumped 19.5% to $24.77 in the pre-market trading session.

Original reporting
Benzinga · Avi Kapoor
Published Oct 8, 2025, 8:43 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2025, 9:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ACXP
Bullish
medium confidence
Mentioned
$ACXP
Relevance
6/10
AlphAI data visualization · based on Benzinga
Decision brief

The 30-second read

$ACXPBullishMed
01

Why it matters

The surge in ACXP suggests increased investor interest, possibly due to sector developments or company-specific news, which could lead to short-term trading opportunities.

02

Market read

The news primarily affects the US technology and life sciences sectors, with potential short-term trading implications for related stocks.

03

What to watch

Broader market conditions, overall sector performance, and upcoming earnings reports could significantly influence stock movements beyond the immediate news.

Relevance 6/10Timing: Immediate to short-term (next 1-3 days)

Background

The article reports a sharp pre-market increase in Confluent Inc shares, driven by acquisition interest, and highlights other stocks moving in pre-market trading.

Company-level read

Ticker impact

$ACXPBullishMedium confidence
Context

High relevance due to recent pre-market trading surge and acquisition interest.

Expected impact

Moderate upward movement expected over the next 1-2 days, approximately 3-5%.

Evidence & confidence

The news highlights a significant pre-market rise driven by acquisition interest, which could lead to short-term gains. However, the overall market sentiment and other factors remain neutral, warranting cautious optimism.

Market effects

Potential positive impact on the Technology and Life Sciences sectors due to acquisition interest and pre-market activity.

Limited; primarily affecting US markets given the focus on NASDAQ-listed stocks.

Low; news pertains mainly to US equities and does not indicate broader global market shifts.

Counterpoint

The pre-market surge in ACXP may be short-lived if acquisition talks do not materialize into a deal, leading to potential reversals.

Key entities

  • Confluent Inc

    A data streaming platform exploring a sale amid acquisition interest.

  • AlphaTON Capital

    A publicly traded company showing a somewhat bullish sentiment.

Related articles

$FDMTMed

Top Biotech Gainers: FDMT, OABI, ACXP Rally On Pipeline And Regulatory News

Biotech gainers were led by 4D Molecular Therapeutics (FDMT), up over 12%, after Phase 3 enrollment progress for 4D-150 in wet AMD and other pipeline updates, plus a $200M credit facility. OmniAb (OABI) rose over 11% on an Eli Lilly collaboration and higher 2026 cash guidance. Acurx (ACXP) gained over 14% after FDA conditional acceptance of CIFBEZY as ibezapolstat’s brand name.

$GOOGLMed

Google's Cheyenne Campus Puts the Cost of AI Power in Writing

Google will invest $399 million in a 702 MW fuel cell project near Cheyenne, Wyoming, under a 20-year power purchase agreement with AEP. AEP plans to invest $4 billion, with construction starting in 2026 and operation expected by 2028. Google's data center will be served by a total resource mix of 2.7 GW, including reserve margins, with Black Hills Corp. managing the output. Google bears all costs, and the agreements run through 2048.

$ALBMed

Albemarle has surprising new reason to rally

Mizuho upgraded Albemarle (ALB) to Outperform, citing growing demand for lithium in battery energy storage systems (BESS). The firm raised its 2027 lithium demand estimate by 10% and increased ALB's price target to $130. Albemarle's Q2 earnings showed strong growth in Energy Storage sales and EBITDA, driven by higher lithium prices. The company's outlook highlights the impact of lithium pricing on its financial performance.

$BXMed

Blackstone’s $100 billion India bet signals long

Blackstone plans to double its investment in India to $100 billion over five years, citing long-term growth prospects. The firm's COO highlights India's strong capital markets. Fairfax Financial Holdings also invested $5.6 billion in IDBI Bank. India's economic formalization, infrastructure investments, and renewable energy expansion have boosted productivity and capital market activity, with significant increases in equity and bond issuances.